News about <![CDATA[XBI]]> News about en-us <![CDATA[ETF Outlook For Wednesday, April 16, 2014 (SMH, IAT, XBI, EWS, INTC, USB)]]> ETF Outlook for Wednesday, April 16, 2014

Market Vectors Semiconductor ETF (NYSE: SMH)

The ETF’s largest holding, Intel ...

]]>
<![CDATA[Biotech ETFs in Bear Market, Plunge Below Key Trendlines]]> ]]> <![CDATA[Biotech Bumble: ETFs Fall to 2014 Lows]]> ]]> <![CDATA[Friday's Downside: The Fun Didn't Last Long]]> The timing of Friday's dance to the downside, which seemingly came out of nowhere, was a bit eerie.

No sooner had we penned a ...

]]>
<![CDATA[Investors Say Bye-Bye to Biotech ETFs]]> ]]> <![CDATA[Biotechs Struggling To Find A Bottom]]> The great biotechnology sell-off of 2014 began on February 26 and started as big sell-offs often do: quietly.

The SPDR S&P ...

]]>
<![CDATA[Inverse Biotech Suddenly Cool Kid at ETF Party]]> ]]> <![CDATA[A Tale of Two Headlines]]> After twenty trading days, the U.S. stock market (as defined by the S&P 500 (NYSE: SPY)) has moved a whopping point and a half. ...

]]>
<![CDATA[3 red-hot investment opportunities]]> <![CDATA[Despite S&P 500's New High, Stocks Face Challenges]]> Stocks ended the first quarter with a big rally; the Standard & Poor's 500 Index actually closed -- barely -- at a new high. ...

]]>
<![CDATA[ETF Performance Report: March & Q1]]> ]]> <![CDATA[ETF Insider: Buy On The Dip Prospects March 31st Edition]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Most Searched ETFs: Guess Who’s Coming to Dinner?]]> ]]> <![CDATA[Biotech ETFs Come Back Down To Earth]]> Biotech stocks have been one of the hottest sectors of the market over the last several years and many exchange traded funds have ...

]]>
<![CDATA[Not Just Biotech: Other Momo ETFs Taken to Task]]> ]]> <![CDATA[Overlooked Bearish Biotech ETF Grows Up…Sort Of]]> ]]> <![CDATA[Bulls see doves in Yellen’s comments]]> <![CDATA[Biotech ETFs Flash Buy Signals (XBI, IBB, BBH, ICPT)]]> The hottest sector in the market over the last year has been the biotech stocks. Not even the market sell-offs have been able to ...

]]>
<![CDATA[ETF Outlook For Wednesday, March 12, 2014 (XBI, RSX, WEAT, JJC, COPX)]]> ETF Outlook for Wednesday, March 12, 2014

SPDR S&P Biotech ETF (NYSE: XBI)

The ETF has moved into oversold territory ...

]]>
<![CDATA[Another Long-Term Sell Signal Worth Noting]]> In case you missed it, Friday marked the five-year anniversary of the intraday low of the Credit Crisis bear market.

However, the ...

]]>
<![CDATA[Most Searched ETFs: Russia Sweeps the Podium]]> ]]> <![CDATA[Health Care ETFs Raking in Plenty of Cash]]> ]]> <![CDATA[Most Searched ETFs: Getting Paid to Play]]> ]]> <![CDATA[Another Reason to Study Your Biotech ETF’s Holdings]]> ]]> <![CDATA[Holy Health Care: This Week’s Most Searched ETFs]]> ]]> <![CDATA[Why This Biotech ETF Leads the Pack]]> ]]> <![CDATA[Health Care ETFs Face Lofty Valuations]]> ]]> <![CDATA[Biotech And Natural Gas ETFs On A Roll]]> Shares of the following exchange traded funds are trading more than 20 percent higher than 90 days ago, and they are within 10 percent of their 52-week highs.

This set of ETFs provides a peek at areas of investor interest during and after the holiday shopping season, as uncertainty over

]]>
<![CDATA[Another Big Week of Biotech Earnings]]> ]]> <![CDATA[This Week’s Most Searched ETFs: Commodities Reign]]> ]]> <![CDATA[Behind XBI’s 2014 Tear]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[An Emerging Theme Among This Week’s Most Searched ETFs]]> ]]> <![CDATA[A Healthy Look at This Week’s Most Searched ETFs]]> ]]> <![CDATA[Why One Biotech ETF Is Standing Out From The Rest]]> ]]> <![CDATA[The Right ETF for Biotech Takeover Targets]]> ]]> <![CDATA[ETF Insider: Best & Worst Weekly Performers January 11th Edition]]> Click here to read the original article on ETFdb.com.

Related Posts:

]]>
<![CDATA[Few Surprises Among This Week’s Popular Searches on ETF Trends]]> ]]> <![CDATA[Tiny Stocks Could Mean Big Gains for This Biotech ETF]]> ]]> <![CDATA[ETF Outlook for Friday, January 10, 2014 (IYT, RSX, EWZ, XBI)]]> ETF Outlook for Friday, January 10, 2014

iShares Dow Jones Transportation Average ETF (NYSE: IYT)

A major outperformer yesterday was the transportation stock, led by a big rally in the airlines. The sector was led by a 6.8 percent gain in United Continental Holdings (NYSE: UAL) and a

]]>
<![CDATA[The One ETF Really Benefiting From the Intercept Pharma News]]> ]]> <![CDATA[Trade of the Day: Long CLDX]]> Long Celldex Therapeutics Inc (CLDX) Thursday, January 2, 2014

 

Company Symbol Industry Rating YTD % Gain Target Stop Celldex Therapeutics Inc CLDX Biotechnology 9.6 +0.00% $28.95 $21.64

The Trade:  

After rough October and November months, Biotech (XBI) finished the year on a high note, back up towards yearly highs. Today, one of its constituents looks like a great buy

]]>
<![CDATA[ETF Insider: Buy On The Dip Prospects December 30th Edition]]> Click here to read the original article on ETFdb.com.

Related Posts:

Is it Time to Sell?

With the market set to the end the year at all-time highs, it seems that many are eager to ring alarm bells. Before you start stuffing cash under your mattress, you should read Bernie Schaeffer's new 2014 Market Forecast - yours FREE.

Discover two explosive stocks on the rise, which sector is primed to breakout, and the three crucial technical levels to watch.

Download FREE today!

]]>
<![CDATA[3 top trades for 2014]]> <![CDATA[Trade Idea of the Day: Short Vertex]]> Vertex Pharmaceuticals (NASDAQ: VRTX) has a technical set-up that had gone from bad to worse entering the second half of 2013.

Now, it has become downright ugly.

While recent weakness in Biotech (see: XBI) has put some pressure on Vertex, the company did itself no favors with an absolutely

]]>
<![CDATA[Some of 2012’s Best Sector ETFs Kept Soaring in 2013]]> ]]> <![CDATA[Why Clovis Oncology Was The Short Trade Of The Day]]> A short of Clovis Oncology (NASDAQ: CLVS) was today's Trade of the Day as the faltering Biotechnology stock faces an imminent technical peril - the filling of an open gap to the downside.

After a hot start to the year, Biotechnology stocks took a major hit in early October

]]>
<![CDATA[Biotech ETFs Lose Some Shine]]> ]]> <![CDATA[In Pictures: October’s 10 Worst ETFs]]> ]]> <![CDATA[Biotech ETFs: More Tricks Than Treats in October]]> ]]> <![CDATA[ETF Winners on Possible Debt Deal (ITB, XLF, ITA, SOCL, XBI)]]> The stock markets around the globe are blasting higher today on the news of a possible deal to raise the debt ceiling. There has not been any definitive news announced as of yet, however the rumors alone are enough to bring investors back to the market.

With nearly every ETF, sans

]]>